Phosphoramidite used to incorporate a furanocoumarin into an oligonucleotide, with a C2 spacer.
Used to 'cap' unreacted OH groups during oligo synthesis cycle, to prevent unwanted side reactions.
Used to oxidise the unstable trivalent phosphite triester linkage to the stable pentavalent phosphotriester during the oligo synthesis cycle.
Used to oxidise the unstable trivalent phosphite triester linkage to the stable pentavalent phosphotriester during the oligo synthesis cycle.
Used to oxidise the unstable trivalent phosphite triester linkage to the stable pentavalent phosphotriester during the oligo synthesis cycle.
Modified nucleoside synthon.
CPG synthesis column for incorporation of unmodified dT at 3' end of an oligonucleotide.
Phosphoramidite diluent or used to wash unwanted/unbound nucleotide and modified oligo reagents from growing oligo chain during oligo synthesis cycle.
Used to oxidise the unstable trivalent phosphite triester linkage to the stable pentavalent phosphotriester during the oligo synthesis cycle.
A tetrazole-like product used in the activation step of the oligo synthesis cycle.
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 1663 54600 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |
